ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,121.24
0.00%
Dow Jones
37,903.29
0.23%
Gold vs US Dollar
2,316.73
-0.32%
Brent Oil
83.91
0.44%
Bitcoin
57,545.30
-1.19%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Abbott Laboratories (ABT)

  7. Abbott Laboratories (ABT) News

Abbott Laboratories (ABT)

Abbott Laboratories
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ABT
DateTimeSourceHeadlineSymbolCompany
29/04/202414:00PR Newswire (US)Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneeNYSE:ABTAbbott Laboratories
17/04/202416:37IH Market NewsAbbott Laboratories Reports Strong Q1 Sales Growth Amid Earnings Decline, Raises Full-Year GuidanceNYSE:ABTAbbott Laboratories
17/04/202412:30PR Newswire (US)Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance RangesNYSE:ABTAbbott Laboratories
17/04/202411:59IH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:ABTAbbott Laboratories
03/04/202412:12IH Market NewsCal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and MoreNYSE:ABTAbbott Laboratories
02/04/202414:00PR Newswire (US)Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart ValveNYSE:ABTAbbott Laboratories
01/04/202414:00PR Newswire (US)Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's BedsideNYSE:ABTAbbott Laboratories
27/03/202420:30PR Newswire (US)Abbott Hosts Conference Call for First-Quarter EarningsNYSE:ABTAbbott Laboratories
19/03/202412:00PR Newswire (Canada)Une première au Canada -- Abbott fait progresser le traitement de la douleur chronique grâce au plus petit système de stimulation de la moelle épinière implantée et rechargeable au mondeNYSE:ABTAbbott Laboratories
19/03/202412:00PR Newswire (Canada)Canadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation SystemNYSE:ABTAbbott Laboratories
06/03/202414:00PR Newswire (US)Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 DiabetesNYSE:ABTAbbott Laboratories
05/03/202400:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
05/03/202400:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
05/03/202400:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
05/03/202400:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
05/03/202400:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
05/03/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/03/202423:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/03/202423:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/03/202423:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/03/202423:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
01/03/202422:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
01/03/202422:45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
01/03/202422:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
01/03/202422:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
01/03/202422:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
01/03/202422:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
27/02/202423:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
23/02/202422:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
23/02/202422:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
 Showing the most relevant articles for your search:NYSE:ABT

Your Recent History

LSE
IES
Invinity Energy Systems
LSE
SCE
Surface Transforms
LSE
RCH
Reach
LSE
SNWS
Smiths News
LSE
UPS
LSE
VAST
Vast Resources
LSE
BARC
Barclays
LSE
GOLD
LSE
I3E
I3 Energy
LSE
JAY
Bluejay Mining
LSE
GKP
Gulf Keystone Petroleum
LSE
ASC
Asos
LSE
GGP
Greatland Gold
LSE
NFDS
Northern Foods
LSE
VSL
Vpc Specialty Lending In...
LSE
PANR
Pantheon Resources
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved